Restricted accessResearch articleFirst published online 2019-8
RETRACTED: The target therapeutic effect of functionalized graphene oxide nanoparticles graphene oxide–polyethylene glycol–folic acid-1–pyrenemethylamine hydrochloride-mediated RNA interference of HIF-1α gene in human pancreatic cancer cells
JiSXuJZhangBet al.
RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy. Cancer Biol Ther2012;
13: 206.
2.
DengSMZhangBWuYWet al.
Early monitoring of response to antimetablic treatment of gemcitabine: a comparison of 18F-FLT and 18F-FDG uptake in Patu8988 human pancreatic carcinoma cells. Nucl SCI Tech2011;
22: 293–298.
3.
FanGLBoJLWanRMet al.
The effect of lentiviral vector-mediated RNA interference targeting hypoxia-inducible factor 1α on the uptake of fluorode-oxyglucose (18F) in the human pancreatic cancer cell line, patu8988. Cancer Biother Radiopharm2015;
30: 160.
4.
KeithBJohnsonRSSimonMC.HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer2011;
12: 9.
5.
KoivunenPHirsilaMRemesAMet al.
Inhibition of hypoxia-inducible factor(HIF)hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem2007;
282: 4524–4532.
6.
RuppJGieffersJKlingerMet al.
Chlamydia pneumoniae directly interferes with HIF-1 alpha stabilization in human host cells. Cell Microbiol2007;
9: 2181–2191.
7.
SemenzaGLWangGL.A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol1992;
12: 5447–5454.
8.
CouvelardAO’TooleDLeekRet al.
Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas. Histopathology2005;
46: 668–676.
9.
GrayMJZhangJEllisLMet al.
HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene2005;
24: 3110–3120.
10.
ZhangJJWuHSWangLet al.
Expression and significance of TLR4 and HIF-1α in pancreatic ductal adenocarcinoma. World J Gastroenterol2010;
16: 2881–2888.
11.
CostaAFTassoMGMarianoFVet al.
Levels and patterns of expression of hypoxia-inducible factor-1α, vascular endothelial growth factor, glucose transporter-1 and CD105 in adenoid cystic carcinomas with high-grade transformation. Histopathology2012;
60: 816–825.
12.
GondiCSRaoJS.Concepts in in vivo siRNA delivery for cancer therapy. J Cell Physiol2009;
220: 285–291.
HuangCYangGJiangTet al.
Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growth. World J Gastroenterol2011;
17: 2992–3001.
15.
ZhaoGCuiJZhangJGet al.
SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells. Gene Ther2011;
18: 920–928.
16.
WeitmanSDLarkRHConeyLRet al.
Distribution of the folate receptor GP38 in normal andmalignant cell lines and tissues. Cancer Res1992;
52: 3396–3401.
17.
RossJFChaudhuriPKRatnamM.Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer1994;
73: 2432–2443.
18.
YehudaGAChristopherPLJosephAR.The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Res Updates2014;
17: 89.
19.
HiroshiKSonshinTTaisakuKet al.
Clinical significance of folate receptor β-expressing tumor-associated macrophages in pancreatic cancer. Ann Surg Oncol2012;
19: 2264–2271.
20.
ZhangYKohlerNZhangM.Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials2002;
23: 1553–1561.
21.
SunCSzeRZhangM.Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J Biomed Mater Res2006;
78: 550–557.
22.
WangSShiXVan AntwerpMet al.
Dendrimer-functionalized iron oxide nanoparticles for specific targeting and imaging of cancer cells. Adv Funct Mater2007;
17: 3043–3050.
23.
ShiXWangSSwansonSDet al.
Dendrimer-functionalized shell-crosslinked iron oxide nanoparticles for in-vivo magnetic resonance imaging of tumors. Adv Mater2008;
20: 1671–1678.
24.
LiuZRobinsonJTSunXet al.
PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc2008;
130: 10876–10877.
25.
SunXLiuZWelsherKet al.
Nano-graphene oxide for cellular imaging and drug delivery. Nano Res2008;
1: 203–212.
26.
LiuZTabakmanSWelsherKet al.
Carbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug delivery. Nano Res2009;
2: 85–120.
27.
LiuZCaiWHeLet al.
In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol2007;
2: 47–52.
28.
ZamaniMRostamiMAghajanzadehMet al.
Mesoporous titanium dioxide@ zinc oxide–graphene oxide nanocarriers for colon-specific drug delivery. J Mater Sci2018;
53: 1634–1645.
29.
RostamiMAghajanzadehMZamaniMet al.
Sono-chemical synthesis and characterization of Fe 3O 4@mTiO 2-GO nanocarriers for dual-targeted colon drug delivery. Res Chem Intermed2018;
44: 1889–1904.
30.
YangKZhangSZhangGet al.
Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett2010;
10: 3318–3323.
31.
NiuGLZhuJPWenYKet al.Preparation of hTERTsiRNA loaded functionalized graphene and its influence on hela. Acta Scientiarum Naturalium Universitatis Nankaiensis (Nat Sci Ed)2013;
46: 35–40.
32.
VinkemeierUMoarefiIDarnellJEet al.
Structure of the amino-terminal protein interaction domain of STAT-4. Science1998;
279: 1048–1052.
33.
HanzeJEulBGSavaiRet al.
RNA interference for HIF-1αinhibits its downstream signaling and affects cellular proliferation. Biochem Biophys Res Commun2003;
312: 571–577.
34.
JungFHaendelerJHoffmannJet al.
Hypoxic induction of the hypoxia-inducible factor is mediated via the adaptor protein Shc in endothelial cells. Circ Res2002;
91: 38–45.
35.
KelmanZO’DonnellM.Structural and functional similarities of prokaryotic and eukaryotic DNA polymerase sliding clamps. Nucleic Acids Res1995;
23: 3613–3620.
36.
WangSC.PCNA: a silent housekeeper or a potential therapeutic target?Trends Pharmacol Sci2014;
35: 178–186.